LANCET MICROBE 润色咨询

Lancet Microbe

出版年份:2020 年文章数:106 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2024-03-25 ms2000000045208894 来自香港

    偏重的研究方向:微生物组;益生菌
    经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2023-12-10 邓凯 来自四川省

    这个with editor时间也太久了吧

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2024-01-24 ms4000000924669021 来自广东省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:呼吸道微生物组
    经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2024-01-25 duololo 来自上海

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向:微生物
    经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2022-03-29 小迎迎

    这个杂志with editor一般多久呀?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2022-04-05 AbC猪

    从3.21到现在一直with editor 正常吗? 求保佑送外审

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    为什么期刊要求用三线表/使用三线表的意义何在?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    什么时候使用柱状图,什么时候使用折线图?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2020-10-05 guolihuihelan_91618321

    我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal
    COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2195325, encodeId=da3f2195325dd, content=偏重的研究方向:微生物组;益生菌<br>经验分享:submitted to journal 一个月没有动静,desk reject都那么慢,真的谨慎投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5669230982, createdName=ms2000000045208894, createdTime=Mon Mar 25 21:23:47 CST 2024, time=2024-03-25, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2173954, encodeId=056621e395455, content=这个with editor时间也太久了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6Z8ZWzwoxxIAurMNW7AZDfIiadvWUCibIVNrexHPWrMIdOVuf8H8ccBF2ruGpZl0ibbZylPTIab8MUhG5sWaQyxhg/132, createdBy=21da5285289, createdName=邓凯, createdTime=Sun Dec 10 02:17:36 CST 2023, time=2023-12-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2183643, encodeId=16cf21836435a, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:呼吸道微生物组<br>经验分享:23年11月17日送审的,12月15日才拒稿,都没送审,还要一个月拒稿,要拒早点拒稿,拖拖拉拉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5d28338005, createdName=ms4000000924669021, createdTime=Wed Jan 24 11:28:35 CST 2024, time=2024-01-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183910, encodeId=d31e218391022, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:微生物<br>经验分享:太慢了!!慎投,23年12月19日投稿,24年1月25日依旧是“Submitted to Journal”状态,甚至连编辑都没分配,发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9703uialMYTDbw5ia09iaFPoiceroiaks9pftbvbzLJHUEFia23nJMT3cs3BFnrNG1xviaHbuQ1sYM41ve0savdGMScVQ/132, createdBy=f56f2538396, createdName=duololo, createdTime=Thu Jan 25 17:31:35 CST 2024, time=2024-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1206783, encodeId=689d1206e83f0, content=这个杂志with editor一般多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=小迎迎, createdTime=Tue Mar 29 07:32:23 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208799, encodeId=165a1208e99eb, content=从3.21到现在一直with editor 正常吗? 求保佑送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/x3zaA8ibdNOzl5C5ot3vmRP7fhvtMIibLLQ1roy9Vc9rybhichx5Z9ggtuJrtYa7nepc0dhpTibQLo8R55z0T0bEnQ/0, createdBy=985d2236237, createdName=AbC猪, createdTime=Tue Apr 05 17:11:52 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113937, encodeId=3533111393e78, content=为什么期刊要求用三线表/使用三线表的意义何在?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113938, encodeId=e1ca1113938f3, content=什么时候使用柱状图,什么时候使用折线图?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890148, encodeId=34e889014890, content=我参与的一篇新冠肺炎的研究“Viral presence and immunopathology in patients with lethal<br>COVID-19: a prospective autopsy cohort study”, 很多实验室都参与了,我们课题组其实做了很大的贡献Fig4+Fig2(Fig2 是跟其他课题组平行做了对照, 最后用的是其他课题组提供的照片),本来投了Lancet,后来被转到了这个子刊Lancet Microbe,我和老板不同意在这个子刊上发表,觉得转到大子刊或Blue Journal 差不多也能接收。 但一作和通讯说先审一下看看,被拒了再投blue journal, 我们说也可以,柳叶刀期刊的学术声誉还是被同行认可的,娘的,后来直接接收了, 感觉被坑了(5月26日投lancet,两周后被转到这个新子刊, 一个月后返修,都是些问答交流解释,文章数据进一步精简优化, 不需要补实验, 返给编辑直接接收了,九月份online, 后来这篇研究论文, 还被荷兰的两家报纸做了头版报道)。但是审稿人还是非常负责人的, 我们收到的四个审稿人的意见, 还有一些审稿人的意见被编辑简单汇总到了一起,一共20页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Mon Oct 05 01:55:15 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904671, encodeId=c1199046e1d8, content=审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>偏重的研究方向:流行病学;传染病;基因组<br>经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。<br>编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce64864080, createdName=shencong456, createdTime=Thu Dec 03 20:59:19 CST 2020, time=2020-12-03, status=1, ipAttribution=)]
    2020-12-03 shencong456

    审稿速度:2.0 | 投稿命中率:25.0 | 版面费用:5000.0
    偏重的研究方向:流行病学;传染病;基因组
    经验分享:投Lancet其他期刊被transfer到这个新子刊,暂时没有IF在国内比较吃亏,不过看目前已发表的article,质量都比较高,citation也不错,IF应该不会低。
    编辑和审稿人很负责,4个审稿人,还另请了一个统计学审稿人,提的问题很多很细致,response letter写了二十多页。

    0

共22条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分